PLS: Lithium Giant - Premium Price, Trough Reality
Pilbara Minerals analysis: Current $2.20 vs fair value $0.85, SELL rating, extreme overvaluation despite operational excellence and tier-one assets.
View notePilbara Minerals analysis: Current $2.20 vs fair value $0.85, SELL rating, extreme overvaluation despite operational excellence and tier-one assets.
View noteIncome LIC trading at unsustainable 22.3% premium to NTA. Fair value $1.30 vs current $1.41. Systematic advantages eroding, competitive pressure mounting.
View notePropel Funeral Partners trades at $5.04 vs $3.83 fair value with 32% overvaluation despite solid fundamentals and demographic tailwinds creating asymmetric downside risk.
View noteTrading at 5.1x EBITDA vs peer median 12.5x, fair value $0.645 vs current $0.26 implies 148% upside through demographic tailwinds and platform integration.
View noteHOLD rating with $10.78 fair value vs $11.20 current price. Market leader with 25.8% share, 5.1% dividend yield, facing battery execution risks.
View noteOrora trades at A$1.89 versus A$2.38 fair value with 26% upside potential. Strong market positions offset by customer concentration risks and integration challenges.
View noteHealthcare IT company trading at $0.24 vs $0.095 fair value. Strong recurring revenue model offset by execution risks and EMR competition. 60% overvalued.
View noteMarket leader oOh!media trades at $1.77 vs fair value $1.27. EBITDA margins 19.7%, market share 30% but facing government capture risks and competitive erosion.
View noteGovernment software leader trading at 41.6x EBITDA vs 18.5x peers. Fair value $8.71 implies -55% downside. Strong moats face Microsoft threat.
View noteStrong Sell rating with fair value $0.26 vs current $0.85. EBITDA margins of 45.7% unsustainable as gold prices normalise from record highs.
View noteNuix trades at $2.48 vs fair value $1.78. Neo platform shows 132% growth but faces 60% AI disruption probability. EBITDA margins 16.8%, churn rising to 7.1%.
View noteDevelopment-stage uranium leader with 3.10% ore grade advantage. Fair value $12.83 CAD vs current price, 82.7% projected EBITDA margins, binary regulatory catalyst November 2025.
View note